BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 21831866)

  • 1. Absorbed dose assessment of cardiac and other tissues around the cardiovascular system in brachytherapy with 90Sr/90Y source by Monte Carlo simulation.
    Saghamanesh S; Karimian A; Abdi M
    Radiat Prot Dosimetry; 2011 Sep; 147(1-2):296-9. PubMed ID: 21831866
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monte Carlo dose characterization of a new 90Sr/90Y source with balloon for intravascular brachytherapy.
    Wang R; Li XA; Lobdell J
    Med Phys; 2003 Jan; 30(1):27-33. PubMed ID: 12557975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Monte Carlo calculation of dosimetric parameters of 90Sr/90Y and 192Ir SS sources for intravascular brachytherapy.
    Wang R; Li XA
    Med Phys; 2000 Nov; 27(11):2528-35. PubMed ID: 11128305
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monte carlo parametric study of stent impact on dose for catheter-based intravascular brachytherapy with 90Sr/90Y.
    Ortego PM; Prieto C; Vano E
    Med Phys; 2004 Jul; 31(7):1964-71. PubMed ID: 15305447
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dosimetric effect of source centering and residual plaque for beta-emitting catheter based intravascular brachytherapy sources.
    Sehgal V; Li Z; Palta JR; Bolch WE
    Med Phys; 2001 Oct; 28(10):2162-71. PubMed ID: 11695779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monte Carlo dose calculations of beta-emitting sources for intravascular brachytherapy: a comparison between EGS4, EGSnrc, and MCNP.
    Wang R; Li XA
    Med Phys; 2001 Feb; 28(2):134-41. PubMed ID: 11243335
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimization of a 90Sr/90Y radiation source train stepping for intravascular brachytherapy.
    Miften MM; Das SK; Shafman TD; Marks LB
    Med Phys; 2002 Dec; 29(12):2891-6. PubMed ID: 12512724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IVBTMC, a Monte Carlo dose calculation tool for intravascular brachytherapy.
    Chibani O; Li XA
    Med Phys; 2003 Jan; 30(1):44-51. PubMed ID: 12557978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dose effects of stents in intravascular brachytherapy for in-stent restenosis: a Monte Carlo calculation.
    Li XA
    Int J Radiat Oncol Biol Phys; 2003 Mar; 55(3):842-8. PubMed ID: 12573772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of EGS4/PRESTA multiple-scattering algorithms for 90Sr/90Y intravascular brachytherapy dosimetry.
    Wang R; Li XA; Yu CX
    Phys Med Biol; 2000 Aug; 45(8):2343-52. PubMed ID: 10958198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dosimetric comparison of two 90Sr/90Y sources for intravascular brachytherapy: an EGSnrc Monte Carlo calculation.
    Wang R; Li XA
    Phys Med Biol; 2002 Dec; 47(23):4259-69. PubMed ID: 12502048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of a high-dose-rate 90Sr-90Y source for intravascular brachytherapy by using the Monte Carlo code PENELOPE.
    Asenjo J; Fernández-Varea JM; Sánchez-Reyes A
    Phys Med Biol; 2002 Mar; 47(5):697-711. PubMed ID: 11931465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extrapolation chamber measurements of 90Sr + 90Y beta-particle ophthalmic applicator dose rates.
    Deasy JO; Soares CG
    Med Phys; 1994 Jan; 21(1):91-9. PubMed ID: 8164595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimal source position for irradiation of coronary bifurcations in endovascular brachytherapy with catheter based beta or iridium-192 sources.
    Marijnissen JP; Coen VL; van der Giessen WJ; de Pan C; Serruys PW; Levendag PC
    Radiother Oncol; 2004 Apr; 71(1):99-108. PubMed ID: 15066302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GAF film dosimetry of a tandem positioned beta-emitting intravascular brachytherapy source train.
    Iftimia I; Devlin PM; Chin LM; Baron JM; Cormack RA
    Med Phys; 2003 Jun; 30(6):1004-12. PubMed ID: 12852522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized trial of 90Sr/90Y beta-radiation versus placebo control for treatment of in-stent restenosis.
    Popma JJ; Suntharalingam M; Lansky AJ; Heuser RR; Speiser B; Teirstein PS; Massullo V; Bass T; Henderson R; Silber S; von Rottkay P; Bonan R; Ho KK; Osattin A; Kuntz RE;
    Circulation; 2002 Aug; 106(9):1090-6. PubMed ID: 12196334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Verification of absolute dose rates for intravascular brachytherapy beta sources.
    Piessens M; Reynaert N
    Phys Med Biol; 2000 Aug; 45(8):2219-31. PubMed ID: 10958190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Monte Carlo evaluation of the dosimetric characteristics of the EchoSeed Model 6733 (125)I brachytherapy source.
    Sowards KT; Meigooni AS
    Brachytherapy; 2002; 1(4):227-32. PubMed ID: 15062171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Considerations on radiation source selection and utilization in vascular brachytherapy.
    Crocker I
    J Invasive Cardiol; 2003 Nov; 15(11):664-7; quiz 668. PubMed ID: 14608142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of off-centering on dose uniformity along and around blood vessels undergoing catheter-based intravascular brachytherapy.
    Nath R; Yue N
    Cardiovasc Radiat Med; 2004; 5(2):88-96. PubMed ID: 15464946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.